GMA-161: Clinical Trials

1 trial of GMA-161, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow GMA-161: new trials by email Literature Review of GMA-161 trials Research Report on GMA-161

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
GMA161 - Idiopathic Thrombocytopenic Purpura
Phase 1TerminatedGenzyme, a Sanofi Company102005-08-012015-04-09

Conditions studied

Purpura, Thrombocytopenic, Idiopathic (1)

Sponsors

Genzyme, a Sanofi Company (1)

Countries

United States (1)